Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001225208-17-005371)

Filing Details

Accession Number:: 0001225208-17-005371
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2017-03-02 17:16:15
Reporting Period:: 2017-02-28

Filing Date:: 2017-03-02
Accepted Time:: 2017-03-02 17:16:15
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
200406	Johnson & Johnson	JNJ	Pharmaceutical Preparations (2834)	221024240

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1673416	J Gary Pruden	One Johnson &Amp; Johnson Plaza New Brunswick NJ 08933	Exec Vp, Ww Chair, Med Devices	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2017-02-28	16,299	$122.21	43,630	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	96	Indirect	By ESOP

Footnotes

This transaction was executed in multiple trades at prices ranging from $122.16 to $122.26. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.